Invasive Fungal Infection Market Increase in the R&D activities for Candidiasis

According to Precision Business Insights' (PBI), latest report, the market value of the Invasive Fungal Infection Market size was valued at USD 10,245 million in 2023 and is projected to reach USD 13,447 million by 2030, growing at a 3.3% CAGR during forecast period 2024 to 2030. The primary factors that drive the market are the growing prevalence of invasive fungal infections such as Candidemia and Invasive Candidiasis, Intra-Abdominal Candidiasis, Cryptococcal Meningitis, and others, rising well-developed healthcare infrastructure, and increasing demand for treatment techniques for such diseases.

View The Detailed Report Description Here - https://www.precisionbusinessinsights.com/market-reports/invasive-fungal-infection-market

THE INVASIVE FUNGAL INFECTION MARKET DETAILED SEGMENTATION
Based on the disease type, the market is segmented into the following
• Candidemia and Invasive Candidiasis
• Intra-Abdominal Candidiasis
• Cryptococcal Meningitis
• Esophageal Candidiasis
• Histoplasmosis Acute Pulmonary
• Others

Based on the drug type, the market is segmented into the following
• Polyenes
• Triazoles
• Echinocandins
• Flucytosine
• Others

Based on the distribution channel, the market is segmented into the following
• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce

Echinocandin to Dominate the Invasive Fungal Infection Market:
Based on drug type, echinocandin holds the highest market share. The major factor for the rise of this segment is due to effective response, echinocandin drugs such as fluconazole, amphotericin B, and others eradicate adverse reactions throughout the treatment. Infection diseases become the major diseases across the world, and low immune systems lead to the occurrence of fungal infections such as dermophytes, candidiasis, Esophageal Candidiasis, and acute pulmonary infections become rare infections in the present era. According to the Centers for Disease Control and Prevention, in 2018 it is estimated around 1.7 million of the hospitalized population suffered from nosocomial infection while being treated for some health complications, and more than 98,000 people died due to hospital-acquired infections consequence of high demands for prevention tools which drives the invasive fungal infection.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=907747

Based on the region, the market is segmented into the following
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Asia Pacific Invasive Fungal Infection Market:
Asia Pacific region is expected to grow significantly in the Invasive Fungal Infection Market size over the forecast period. The Invasive Fungal Infection Market in the Asia Pacific hold significant revenue share in 2022 due to the high prevalence of chronic and acute fungal infection patients, increased research and development activities by the key players and it is attributed to rising spending on healthcare infrastructure, it is predicted to grow at a significant rate.

Request Methodology: https://www.precisionbusinessinsights.com/request-methodology/?product_id=907747

STRATEGIC NEW PRODUCT LAUNCHES, MERGERS, ACQUISITIONS, AND AGREEMENTS ARE THE KEY STRATEGIES ADOPTED BY MARKET PLAYERS:
The global Invasive Fungal Infection Market further reveals that the key players are implementing strategies such as the extension of product collection through research and development activities, product launches, acquisitions, mergers, and strategic alliances to improve their market position and strengthen the market revenue share.

Key players' profiles in the Invasive Fungal Infection Market report are Abbott Laboratories Inc., Cidara Therapeutics Inc., Basilea Pharmaceutical, Pfizer Inc., Astellas Pharma Inc., GSK plc, Merck & Co., Bayer AG, F2G Ltd., Scynexis, Inc., and Pulmocide Ltd.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.